Characterizing Late-season Influenza Vaccine Responses to Compare the 2023 and 2024 Vaccine Formulations
Clinical trial NCT06567860 · COMPLETED
Trial details
- NCT number
- NCT06567860
- Sponsor
- La Jolla Institute for Immunology
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-21
- Primary completion
- 2025-02-06
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.